BI
BIOGEN INC
BIIB· Health Care· BiotechnologyS&P 500
Close · 23/10/2026
250.69
1D
-1.24%52-week range
138 – 254.41
Volume
11,57,400.00
Price history
BIIB
24/09/2026 to 23/10/2026
O 251.68 H 252.44 L 246.15
1W+7.75%
1M+10.75%
3M+25.26%
6M+35.96%
1Y+69.71%
3Y-4.86%
5Y-10.85%
MAX-26.64%
Fundamentals
as of 23/10/2026- Market cap
- $37.01B
- Shares out
- 147.64M
- P/E (trailing)
- 26.98
- P/E (forward)
- 15.25
- EPS (trailing)
- 9.29
- Dividend yield
- 0.00%
- Beta
- 0.09
- Profit margin
- 13.81%
- P/B
- 1.98
- Return on equity
- 7.36%
SEC financial statements
66 quarterly and 19 annual periods through 31/03/2026.
Details
- Ticker
- BIIB
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 23/10/2026.
Tracked by Congress
12 filers · 2 on watchlist · 15 buys · 9 sells · ?: 9 · D: 6 · R: 9
- 24/09/2026Maria Elvira SalazarSell+Biogen Inc. - Common Stock$1,001–$15,000
- 18/08/2026Kevin HernWSellBiogen Inc. - Common Stock$1,001–$15,000
- 27/03/2026Alan ArmstrongBuyBiogen Inc. - Common Stock$1,001–$15,000
- 02/06/2026Maria Elvira SalazarSellBiogen Inc. - Common Stock$15,001–$50,000
- 05/06/2026Gilbert CisnerosBuyBiogen Inc. - Common Stock$1,001–$15,000
- 12/05/2026Maria Elvira SalazarBuyBiogen Inc. - Common Stock$1,001–$15,000
- 11/05/2026Maria Elvira SalazarBuyBiogen Inc. - Common Stock$1,001–$15,000
- 11/05/2026Maria Elvira SalazarBuyBiogen Inc. - Common Stock$50,001–$100,000